VIA
MRNA icon

Vident Investment Advisory’s Moderna MRNA Stock Holding History

Vident Investment Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,844
Closed -$831K – 643
2023
Q2 		$831K Sell
6,844
-7,824
-53% -$1.04M 0.03% 529
2023
Q1 		$2.25M Sell
14,668
-3,073
-17% -$507K 0.07% 304
2022
Q4 		$3.19M Buy
17,741
+2,275
+15% +$372K 0.12% 199
2022
Q3 		$1.69M Buy
15,466
+13,860
+863% +$2.1M 0.05% 418
2022
Q2 		$223K Sell
1,606
-14,725
-90% -$2.1M 0.01% 1097
2022
Q1 		$2.81M Buy
16,331
+10,817
+196% +$1.82M 0.07% 299
2021
Q4 		$1.4M Buy
5,514
+1,123
+26% +$328K 0.04% 594
2021
Q3 		$1.69M Sell
4,391
-6,609
-60% -$2.44M 0.05% 505
2021
Q2 		$2.58M Sell
11,000
-10,886
-50% -$1.95M 0.08% 298
2021
Q1 		$2.87M Sell
21,886
-4,894
-18% -$709K 0.1% 213
2020
Q4 		$2.8M Sell
26,780
-32,692
-55% -$3.31M 0.11% 164
2020
Q3 		$4.21M Sell
59,472
-38,852
-40% -$2.71M 0.21% 92
2020
Q2 		$6.31M Buy
98,324
+19,220
+24% +$1.05M 0.33% 67
2020
Q1 		$2.37M Sell
79,104
-4,646
-6% -$107K 0.16% 135
2019
Q4 		$1.64M Sell
83,750
-3,660
-4% -$64.9K 0.1% 310
2019
Q3 		$1.39M Sell
87,410
-2,497
-3% -$36.9K 0.12% 122
2019
Q2 		$1.32M Buy
89,907
+7,592
+9% +$163K 0.11% 135
2019
Q1 		$1.68M Sell
82,315
-2,075
-2% -$38.5K 0.09% 317
2018
Q4 		$1.29M Buy
+84,390
New +$1.39M 0.07% 366

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Vident Investment Advisory's MRNA Position: Q3 2023 in Review

Vident Investment Advisory sold out of Moderna (MRNA) in Q3 2023, closing a stake of 6,844 shares — an estimated $831K sold.

Vident Investment Advisory first reported a position in MRNA in Q4 2018 and held it in 19 quarters. The position peaked at $6.31M in Q2 2020. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Vident Investment Advisory reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 6,844 Moderna shares in Q3 2023, an estimated $831K.
  • Vident Investment Advisory first reported a position in Moderna in Q4 2018 and held it in 19 quarters.
  • Vident Investment Advisory's Moderna position peaked at $6.31M in Q2 2020.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.